Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

By Cryz S.J.   Poovorawan Y.   Theamboonlers A.   Chumdermpadetsuk S.   Gluck R.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 891-893

Elsevier

Access to resources Recommend Favorite

T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice

By Jones C.D.   Page M.   Bacon A.   Cahill E.   Bentley M.   Chatfield S.N.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2528-2537

Elsevier

Access to resources Recommend Favorite

Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

By Tacket C.O.   Roy M.J.   Widera G.   Swain W.F.   Broome S.   Edelman R.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2826-2829

Elsevier

Access to resources Recommend Favorite

Cytokine production patterns and antibody response to measles vaccine

By Ovsyannikova I.G.   Reid K.C.   Jacobson R.M.   Oberg A.L.   Klee G.G.   Poland G.A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3946-3953

Elsevier

Access to resources Recommend Favorite

Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax(R))

By Cho H.-W.   Howard C.R.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2569-2575

Elsevier

Access to resources Recommend Favorite